ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The primary purpose of this study is to evaluate the safety and tolerability of ION337 in participants with Dravet syndrome (DS).
Epistemonikos ID: e3729d9ac715095883d14767a88bd2871c39ca56
First added on: Apr 16, 2026